Who owns the GILA THERAPEUTICS trademark?

The GILA THERAPEUTICS trademark is owned by Gila Therapeutics, Inc..

What is the serial number for GILA THERAPEUTICS?

The USPTO serial number for GILA THERAPEUTICS is 98771131.

What is the registration number for GILA THERAPEUTICS?

GILA THERAPEUTICS is registered under USPTO registration number 0.

GIL

USPTO Trademark Record

PENDING

GILA THERAPEUTICS

Q: What class is the GILA THERAPEUTICS trademark registered in?

The GILA THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98771131·Reg 0·Filed Sep 26, 2024

Owner Gila Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GILA THERAPEUTICS (Serial No. 98771131), Registration No. 0, is a pending US trademark filed on Sep 26, 2024 by Gila Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: March 02, 2027147 days remaining

Mark Intelligence

GILA THERAPEUTICS (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 26, 2024

SERIAL

98771131

REG#

Owner

Applicant

Gila Therapeutics, Inc.

Entity

Corporation

State

Address

5420 Highwood Dr. W, Minneapolis, MN, 55436

Country

Attorney

NameMichael J. Belliveau, Ph.D.

Law firm

Michael J. Belliveau, Ph.D. CLARK+ELBING LLP

Docket

51547-T03001

Address

One Financial Center, Suite 2110, Boston, MA 02111, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateSep 26, 2024

Serial Number98771131

Registration No.0

Status DateSep 01, 2026

Published for OppositionJul 08, 2025

Mark TypeStandard characters

Attorney Docket51547-T03001

Status DescriptionLive and pending, second extension granted

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 02, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 01, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Sep 01, 2026

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Sep 01, 2026

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 28, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 27, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 27, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 27, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 02, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 03, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 07, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 07, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 07, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 10, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 10, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 10, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 02, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 01, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 26, 2024

NEW APPLICATION ENTERED

GILA THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Gila Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Michael J. Belliveau, Ph.D.

Resources

Company